Latest News about Briefs
Recent news which mentions Briefs
Freshpet Surges On Strong Q3 Earnings Beat, 25th Quarter Of Double-Digit Sales Growth: Details
November 04, 2024
From Benzinga
Fox's Q1 Earnings: Revenue And EPS Beat, Political Ads, Tubi Expansion Boosts Growth
November 04, 2024
From Benzinga
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
November 04, 2024
From Benzinga
Ryanair Q2: Revenue Climbs, Traffic Surges, But Boeing Delays And Cost Pressures Weigh On Results
November 04, 2024
From Benzinga
Marriott International Q3 Earnings: China Market Weakness Drags on Performance, Adjusts Full-Year Outlook
November 04, 2024
From Benzinga
Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
November 04, 2024
From Benzinga
From Benzinga
From Benzinga
Loews Reports Strong Q3 With 58% Net Income Surge, Backed by CNA Financial And Boardwalk Pipelines
November 04, 2024
From Benzinga
EXCLUSIVE: Janover Scores New Deal With Real Estate Firm For AI Client Engagement Tools
November 04, 2024
From Benzinga
Roaring Kitty Stock Chewy Set to Join S&P MidCap 400 Index, Will Replace Stericycle
November 04, 2024
From Benzinga
Yum China Q3 Earnings Surprise: KFC & Pizza Hut Power Earnings Beat, Reiterates Capex Plan To Open ~1,500-1,700 Net New Stores
November 04, 2024
From Benzinga
From Benzinga
Super Micro Computer, Li Auto And Estee Lauder Are Among Top 10 Large Cap Losers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
November 03, 2024
From Benzinga
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
November 03, 2024
From Benzinga
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
November 01, 2024
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
From Benzinga
Shell Reports Strong Q3: Analysts Highlight Robust Buybacks Amid Market Challenges
November 01, 2024
From Benzinga
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
November 01, 2024
From Benzinga
ConocoPhillips-Marathon Synergy Will Boost Free Cash Flow And Stock Buyback: Analyst
November 01, 2024
From Benzinga
Uber's Q3 Review: Analysts See Opportunity Amid Growth Slowdown, Strong Margins, And Expanding Autonomous Vehicle Partnerships
November 01, 2024
From Benzinga
What's Going On With Rivian Stock Today?
November 01, 2024
From Benzinga
From Benzinga
Apple Satellite Connectivity Provider Globalstar Stock Surges After Deal Extension
November 01, 2024
From Benzinga
What's Going On With Taiwan Semiconductor and ASML Stocks On Friday?
November 01, 2024
From Benzinga
Phoenix Motor Drops Despite Revenue Surge, New EV Contracts
November 01, 2024
From Benzinga
Why Is Infrastructure Construction Company MasTec Stock Surging Today?
November 01, 2024
From Benzinga
Church & Dwight Surpasses Q3 Expectations: Strong Sales Growth And Brand Investments Fuel Gains
November 01, 2024
From Benzinga
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
November 01, 2024
From Benzinga
LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4
November 01, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.